Johnson & Johnson (NYSE:JNJ) is included among the 12 Best Dividend Paying Stocks to Buy Now.
Johnson & Johnson is a major player in the pharmaceutical and medical device industries, with a recent market value close to $425 billion. The company is also showing growth, as second-quarter revenue increased 5.8% from the previous year and earnings rose 18%.
Until 2023, Johnson & Johnson operated a strong consumer healthcare division that produced well-known products such as Tylenol and Band-Aid. That division was spun off into a separate company called Kenvue.
Johnson & Johnson’s broad portfolio includes immunology treatments like Stelara and Tremfya, as well as cancer drugs such as Darzalex and Erleada. The company also has 40 programs currently in late-stage clinical trials. These trials are evaluating new drug candidates and seeking additional approvals for existing treatments like Stelara and Tremfya.
Johnson & Johnson is popular among income investors because of its generous dividends. The company holds a 63-year track record of dividend growth, which makes it one of the best dividend paying stocks. Currently, it pays a quarterly dividend of $1.30 per share and has a dividend yield of 2.95%, as of September 19.
READ NEXT: 13 Best Consistent Dividend Stocks to Buy Now and Dividend Stock Portfolio For Income: 12 Stocks to Buy Now.
